Home Cart 0 Sign in  
X

[ CAS No. 53088-68-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 53088-68-9
Chemical Structure| 53088-68-9
Chemical Structure| 53088-68-9
Structure of 53088-68-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 53088-68-9 ]

Related Doc. of [ 53088-68-9 ]

Alternatived Products of [ 53088-68-9 ]

Product Details of [ 53088-68-9 ]

CAS No. :53088-68-9 MDL No. :MFCD00800679
Formula : C9H9ClO2 Boiling Point : -
Linear Structure Formula :- InChI Key :HTBBVKFFDDQVER-UHFFFAOYSA-N
M.W : 184.62 Pubchem ID :2733544
Synonyms :

Calculated chemistry of [ 53088-68-9 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.32
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.71 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.34
Log Po/w (XLOGP3) : 2.42
Log Po/w (WLOGP) : 2.06
Log Po/w (MLOGP) : 2.55
Log Po/w (SILICOS-IT) : 2.67
Consensus Log Po/w : 2.41

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.68
Solubility : 0.385 mg/ml ; 0.00208 mol/l
Class : Soluble
Log S (Ali) : -2.61
Solubility : 0.448 mg/ml ; 0.00243 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.5
Solubility : 0.0591 mg/ml ; 0.00032 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.4

Safety of [ 53088-68-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 53088-68-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 53088-68-9 ]
  • Downstream synthetic route of [ 53088-68-9 ]

[ 53088-68-9 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 53088-68-9 ]
  • [ 22908-28-7 ]
Reference: [1] Journal of Organic Chemistry, 1995, vol. 60, # 20, p. 6389 - 6396
  • 2
  • [ 53088-68-9 ]
  • [ 5182-44-5 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1959, vol. 32, p. 1135,1136
[2] Chemische Berichte, 1960, vol. 93, p. 1496 - 1506
  • 3
  • [ 53088-68-9 ]
  • [ 14161-84-3 ]
Reference: [1] Journal of Organic Chemistry, 2003, vol. 68, # 19, p. 7234 - 7242
[2] Patent: US2014/187538, 2014, A1,
  • 4
  • [ 67-56-1 ]
  • [ 1878-65-5 ]
  • [ 53088-68-9 ]
YieldReaction ConditionsOperation in experiment
97.8% at 0 - 20℃; for 3 h; Inert atmosphere; Schlenk technique General procedure: Thionyl chloride (1.06 mL, 14.63 mmol) was added to dropwise the solution of phenyl aceticacid derivatives (1 g, 4.877 mmol) in methanol (10 mL) at 0 . The reaction was allowed to room temperature for 3 h. The reaction mixture was evaporated under reduced pressure. The residue was dissolved ethyl acetate and water. The mixture was extracted with ethyl acetate and washed with sodium hydrogen carbonate aqueous solution. The organic layer was dried over sodium sulfate, filtered and concentrated under reduced pressure to give 6a-f.
Reference: [1] Tetrahedron, 1997, vol. 53, # 38, p. 13149 - 13164
[2] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 13, p. 2843 - 2866
[3] Journal of Medicinal Chemistry, 2001, vol. 44, # 17, p. 2701 - 2706
[4] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 4, p. 1679 - 1693
[5] Tetrahedron Letters, 2003, vol. 44, # 2, p. 331 - 334
[6] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 20, p. 5515 - 5518
[7] Tetrahedron, 2002, vol. 58, # 51, p. 10113 - 10126
[8] Chemische Berichte, 1960, vol. 93, p. 1496 - 1506
[9] Journal of Medicinal Chemistry, 1993, vol. 36, # 23, p. 3738 - 3742
[10] Patent: US2012/252802, 2012, A1, . Location in patent: Page/Page column 77-78
[11] Advanced Synthesis and Catalysis, 2015, vol. 357, # 11, p. 2479 - 2484
[12] Synlett, 2015, vol. 26, # 13, p. 1880 - 1884
[13] Angewandte Chemie - International Edition, 2017, vol. 56, # 14, p. 3987 - 3991[14] Angew. Chem., 2017, vol. 129, # 14, p. 4045 - 4049,5
[15] Journal of Chemistry, 2017, vol. 2017,
[16] Angewandte Chemie - International Edition, 2018, vol. 57, # 32, p. 10357 - 10361[17] Angew. Chem., 2018, vol. 130, p. 10514 - 10518,5
[18] Journal of Agricultural and Food Chemistry, 2018, vol. 66, # 44, p. 11797 - 11805
  • 5
  • [ 1878-65-5 ]
  • [ 74-88-4 ]
  • [ 53088-68-9 ]
YieldReaction ConditionsOperation in experiment
63%
Stage #1: With 1,8-diazabicyclo[5.4.0]undec-7-ene In toluene at 20℃; for 1 h;
Stage #2: at 20℃; for 48 h;
General procedure: To 15 mmol of appropriate phenylacetic acid in 45 mL of dried toluene 15 mmol of DBU was added and the reaction mixture was stirred in roomtemperature for 1 h. After that time 15 mmol of iodomethane was added and stirring was continued for 2 days. Then, the solvent was evaporated, the residuewas dissolved in ethyl acetate and washed with 0.5percent NaOH and brine. Organic layer was dried over anhydrous Na2SO4. Finally, the solvent was evaporated togive the product as colorless oils. 1.2.1. Methyl 2-(3-chlorophenyl)acetate (4e)CAS: 53088-68-9. Colorless oil, yield 63percent, 1H NMR [DMSO-d6] : 7.29-7.34 (m, 3H, Ph-4,5,6-H), 7.20-7.23 (m, 1H, Ph-2-H), 3.71 (s, 2H, Ph-CH2), 3.60 (s, 3H,CH3).
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 135, p. 117 - 124
  • 6
  • [ 1878-65-5 ]
  • [ 53088-68-9 ]
YieldReaction ConditionsOperation in experiment
100% With sulfuric acid In methanol; 1,1-dichloroethane Example 84
4-[1-[3-chloro-4-[1N'-(2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidinyl]methoxybenzoic Acid
To a stirred solution of 3-chlorophenylacetic acid (21.76 g, 127.6 mmol) in dichloroethane (100 ml) was added MeOH (15.6 ml, 383 mmol) and H2SO4 (1 ml) at room temperature.
After 20 minutes stirring, the mixture was heated at 80° C. for 2 h.
The reaction mixture was poured into ice water and extracted with CHCl3.
The combined extracts were washed with aq NaHCO3 and brine.
After dried over Na2SO4, the extract was concentrated in vacuo to give methyl 3-chlorophenylacetate (25.4 g, 100percent) as a colorless oil. 1H-NMR (CDCl3) δ 3.60 (s,21), 3.70 (s, 3H), 7.15-7.26 (m, 4H).
Reference: [1] Patent: US2003/78249, 2003, A1,
  • 7
  • [ 1878-65-5 ]
  • [ 53088-68-9 ]
Reference: [1] Patent: US2014/187538, 2014, A1, . Location in patent: Page/Page column
  • 8
  • [ 7664-93-9 ]
  • [ 1878-65-5 ]
  • [ 53088-68-9 ]
Reference: [1] Patent: US6048893, 2000, A,
[2] Patent: US6124343, 2000, A,
  • 9
  • [ 84508-62-3 ]
  • [ 53088-68-9 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1982, # 11, p. 2575 - 2582
  • 10
  • [ 67-56-1 ]
  • [ 99-02-5 ]
  • [ 53088-68-9 ]
  • [ 247179-34-6 ]
Reference: [1] Tetrahedron Letters, 2007, vol. 48, # 17, p. 3003 - 3007
  • 11
  • [ 124-41-4 ]
  • [ 81447-63-4 ]
  • [ 53088-68-9 ]
Reference: [1] Helvetica Chimica Acta, 1998, vol. 81, # 2, p. 251 - 267
  • 12
  • [ 20667-76-9 ]
  • [ 1878-65-5 ]
  • [ 53088-68-9 ]
  • [ 106-49-0 ]
Reference: [1] Gazzetta Chimica Italiana, 1989, vol. 119, # 8, p. 453 - 456
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 53088-68-9 ]

Aryls

Chemical Structure| 52449-43-1

[ 52449-43-1 ]

Methyl 4-chlorophenylacetate

Similarity: 0.98

Chemical Structure| 55954-23-9

[ 55954-23-9 ]

Methyl 2,4-dichlorophenylacetate

Similarity: 0.96

Chemical Structure| 40061-54-9

[ 40061-54-9 ]

Ethyl 2-(2-chlorophenyl)acetate

Similarity: 0.94

Chemical Structure| 200214-60-4

[ 200214-60-4 ]

Ethyl 2-(3,5-dichlorophenyl)acetate

Similarity: 0.94

Chemical Structure| 14062-24-9

[ 14062-24-9 ]

Ethyl 4-chlorophenylacetate

Similarity: 0.94

Chlorides

Chemical Structure| 52449-43-1

[ 52449-43-1 ]

Methyl 4-chlorophenylacetate

Similarity: 0.98

Chemical Structure| 55954-23-9

[ 55954-23-9 ]

Methyl 2,4-dichlorophenylacetate

Similarity: 0.96

Chemical Structure| 40061-54-9

[ 40061-54-9 ]

Ethyl 2-(2-chlorophenyl)acetate

Similarity: 0.94

Chemical Structure| 200214-60-4

[ 200214-60-4 ]

Ethyl 2-(3,5-dichlorophenyl)acetate

Similarity: 0.94

Chemical Structure| 14062-24-9

[ 14062-24-9 ]

Ethyl 4-chlorophenylacetate

Similarity: 0.94

Esters

Chemical Structure| 52449-43-1

[ 52449-43-1 ]

Methyl 4-chlorophenylacetate

Similarity: 0.98

Chemical Structure| 55954-23-9

[ 55954-23-9 ]

Methyl 2,4-dichlorophenylacetate

Similarity: 0.96

Chemical Structure| 40061-54-9

[ 40061-54-9 ]

Ethyl 2-(2-chlorophenyl)acetate

Similarity: 0.94

Chemical Structure| 200214-60-4

[ 200214-60-4 ]

Ethyl 2-(3,5-dichlorophenyl)acetate

Similarity: 0.94

Chemical Structure| 14062-24-9

[ 14062-24-9 ]

Ethyl 4-chlorophenylacetate

Similarity: 0.94